Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
Rudavsky
A Z
AZ
Department of Nuclear Medicine, Montefiore Medical Center, Bronx, New York 10467, USA.
Freeman
L M
LM
D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D002291:Carcinoma, Papillary / Q000000981:diagnostic imaging / Q000556:secondary / Q000628:therapy*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D011994:Recombinant Proteins / Q000627:therapeutic use; D013954:Thyroglobulin / Q000097:blood*; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D013972:Thyrotropin / Q000627:therapeutic use*
D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D013972:Thyrotropin; D013954:Thyroglobulin